Tessellate BIO Competitors and Similar CompaniesClear all

Tessellate BIO's competitors and similar companies include Lytix Biopharma, Calviri, Blaze Bioscience and BioInvent.

	Tessellate BIO Tessellate BIO is a biotechnology company that specializes in cancer treatment solutions.	Lytix Biopharma Lytix Biopharma is a biotech company developing cancer immunotherapies.	Calviri Calviri is a company that develops diagnostic and therapeutic products, as well as vaccines aimed to prevent cancer.	Blaze Bioscience Blaze Bioscience is a biotechnology company developing tumor paint products and therapeutics for cancer treatment.	BioInvent BioInvent focuses on the discovery and development of antibody-based drugs against cancer.
Founding Date	Founding Date N/A	Founding Date 2003	Founding Date 2018	Founding Date 2010	Founding Date 1997
Type	Type Private	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare biotech drug development medical diagnostics oncology	Tags Healthcare biotech drug development medical diagnostics oncology pharma	Tags Healthcare biotech drug development medical diagnostics oncology pharma	Tags Healthcare biotech drug development medical diagnostics oncology	Tags Healthcare biotech drug development medical diagnostics oncology pharma
Locations	Locations Naarden, NL HQ Stevenage, GB	Locations Oslo, NO HQ	Locations Phoenix, US HQ	Locations Seattle, US HQ	Locations Lund, SE HQ
Employees	Employees 303% increase	Employees 215% increase	Employees 16	Employees 185% decrease	Employees 118
Valuation ($)	Valuation ($) N/A	Valuation ($) 31.4 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 285.9 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) kr226.5m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit kr226.6m (FY, 2025)
Net income	Net income N/A	Net income (kr60m) (FY, 2025)	Net income N/A	Net income N/A	Net income (kr332.9m) (FY, 2025)
Funding
Latest funding round	Latest funding round $ 8.4m (over 2 years ago)	Latest funding round N/A	Latest funding round $ 2.3m (about 6 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 8.4m	Total funding raised $ 10.4m	Total funding raised $ 2.3m	Total funding raised $ 55.4m	Total funding raised N/A